Contents

BNP & NT-proBNP Blood Test: Normal Range & Heart Failure

BNP and NT-proBNP are the heart-failure blood markers. Learn the normal range, what a high result means, how a low value rules out heart failure, and the age and kidney caveats.

Published July 18, 202612 min readWritten by the Blood Analysis Team · Reviewed and verified by Julien Priour

BNP (B-type natriuretic peptide) and NT-proBNP are two closely related blood markers — hormones the heart releases when its walls are stretched by too much pressure or volume. Their levels rise mainly in heart failure, which makes the BNP blood test the go-to marker for detecting and monitoring it. But this test has an unusual strength: it is used as much to rule heart failure out as to confirm it. A low BNP or NT-proBNP makes heart failure unlikely; a high value points toward it but is not proof, because age, kidney disease, an irregular heartbeat, and other conditions push these numbers up too. This guide covers the normal BNP and NT-proBNP range, what a high result means, the crucial difference between the two tests, and the age and kidney caveats.

Key takeaways

  • BNP and NT-proBNP are natriuretic peptides released when the heart's chambers are stretched by pressure or volume overload. Their level reflects the strain on the heart, not damage to it.12
  • BNP and NT-proBNP are two different tests measured in pg/mL. Do not compare a BNP number to an NT-proBNP cutoff — the molecules, thresholds, and behavior differ.34
  • Common rule-out values: BNP below ~35 pg/mL and NT-proBNP below 125 pg/mL in the outpatient setting; in the emergency room the cutoffs are higher (BNP < 100 pg/mL, NT-proBNP < 300 pg/mL), and NT-proBNP is read by age (about 450 / 900 / 1800 pg/mL).56
  • The test's greatest value is the negative result: a low BNP or NT-proBNP has a high negative predictive value and makes heart failure unlikely.67
  • A high value is non-specific: heart failure is the main concern, but age, kidney disease, atrial fibrillation, pulmonary embolism, and sepsis raise it too. Obesity lowers it. No fasting required.89

Normal BNP and NT-proBNP levels

These are indicative adult values. They depend heavily on the assay the lab uses, on age and kidney function, and on whether the test is done in the outpatient setting (a clinic visit) or an acute setting (the emergency room for shortness of breath). Always trust the reference interval printed on your report.

Marker & settingRule-out valueUnit
BNP — outpatientbelow ~35pg/mL
NT-proBNP — outpatientbelow 125pg/mL
BNP — acute (ER)below 100pg/mL
NT-proBNP — acute (ER)below 300pg/mL
NT-proBNP — acute, age-stratified "positive" cutoffs~450 (under 50) · 900 (50–75) · 1800 (over 75)pg/mL

Two different tests — don't cross-compare. Your lab measures either BNP or NT-proBNP, not both at once. They are distinct molecules with their own reference values, even though both are reported in pg/mL (for NT-proBNP, pg/mL and ng/L are the same thing). A BNP of 90 and an NT-proBNP of 90 do not mean the same thing. These markers are used mostly to exclude heart failure: below the cutoff, heart failure is unlikely (high negative predictive value).6 Above it, the number does not confirm the diagnosis on its own — an echocardiogram and the clinical picture do.10 For NT-proBNP in the acute setting, there is no single cutoff: the thresholds rise with age because levels climb naturally as we get older.6

What are BNP and NT-proBNP?

When the heart's chambers — mainly the ventricles — are stretched by an overload of pressure or volume, the heart muscle makes a large precursor molecule called proBNP. As it enters the bloodstream, proBNP is split in two: the active part, BNP, which signals the kidneys to shed sodium and water and helps lower blood pressure, and an inactive fragment, NT-proBNP.21 You can measure either one; they tell the same story — a heart under strain — but with different thresholds and different behavior.

That biology is what sets these markers apart from troponin. Troponin signals injury to heart-muscle cells — the hallmark of a heart attack — while BNP and NT-proBNP reflect a mechanical stress on the walls: the heart straining against an overload.1 The two can rise together — in severe heart failure or a large pulmonary embolism — but they do not measure the same thing, which is why cardiac enzyme tests and natriuretic peptides are often ordered as a complementary pair on a panel of cardiac blood tests.

BNP vs NT-proBNP

This is the single most important thing to understand about the test, and the source of most confusion. BNP and NT-proBNP come from the same proBNP molecule, but they are two different assays with different properties — and they are not interchangeable.34

  • They have different cutoffs. A "normal" BNP number is not a normal NT-proBNP number. Compare each value only to its own reference range.5
  • NT-proBNP is more stable and longer-lived. BNP is the active hormone and clears from the blood relatively quickly; NT-proBNP is inactive, has a longer half-life, and stays measurable longer, which makes its values steadier from draw to draw.42
  • Kidney function matters more for NT-proBNP. Both peptides are cleared partly by the kidneys, so both rise when kidney function falls — but NT-proBNP is affected more. That is one reason NT-proBNP cutoffs are read alongside kidney function tests.8
  • Sacubitril/valsartan (Entresto) raises BNP but not NT-proBNP. This heart-failure drug blocks neprilysin, the enzyme that breaks down BNP. On this treatment, BNP goes up — because it is no longer degraded — while NT-proBNP is unaffected and stays reliable. That is why NT-proBNP is preferred for monitoring anyone taking Entresto.11

The practical takeaway: know which test you had, read the value against its own cutoff, and never map a BNP result onto an NT-proBNP threshold or vice versa.

Why it's measured: ruling heart failure in or out

The defining feature of the BNP/NT-proBNP test is its high negative predictive value — its power to rule heart failure out. A clinician usually orders it to:510

  • investigate shortness of breath (dyspnea) and sort a cardiac cause (heart failure) from a lung cause;
  • detect or confirm heart failure, alongside the physical exam and an echocardiogram;12
  • monitor known heart failure and gauge the response to treatment;13
  • assess risk in people with conditions such as diabetes or high blood pressure, before symptoms appear.8

The reason exclusion is so useful comes straight from the data. In the landmark PRIDE study of 600 emergency-department patients with acute shortness of breath, an NT-proBNP below 300 pg/mL ruled out acute heart failure with a negative predictive value of 99%.6 Earlier, the Breathing Not Properly study established BNP as a rapid bedside tool for the same job — telling heart failure apart from lung disease in patients arriving breathless.7 Because a low value so reliably makes heart failure unlikely, the test often spares patients unnecessary imaging.10

It is not a routine "wellness panel" number. It answers a specific clinical question, almost always centered on heart failure.3

Interpreting your results

A BNP or NT-proBNP is always read together with your symptoms, your age, your kidney function, and — when heart failure is suspected — an echocardiogram. Never on its own.

High BNP/NT-proBNP

A high BNP or NT-proBNP means the heart is under strain — its walls stretched by an overload. The most common cause is heart failure, but it is not the only one. The main possibilities:18

  • heart failure (with reduced or preserved ejection fraction) — the leading explanation for a clearly elevated value;12
  • atrial fibrillation and other arrhythmias, which raise NT-proBNP even without obvious heart failure;8
  • kidney disease — the peptides are cleared partly by the kidneys, so levels rise as kidney function falls, especially NT-proBNP;8
  • older age — levels climb naturally over the years, which is exactly why the acute NT-proBNP cutoffs are age-stratified;6
  • conditions that strain the right side of the heart: pulmonary embolism, pulmonary hypertension, valve disease, and severe sepsis.1

When should you worry? Not the isolated number, but the context: your symptoms (shortness of breath, swollen legs, rapid weight gain?), your age, your kidney function, any arrhythmia, and above all the echocardiogram your physician will order to confirm or exclude heart failure. A mildly high value in an older or kidney-impaired person does not carry the same weight as a markedly high value with breathlessness. The interpretation belongs to the physician: these markers point the way, imaging confirms.12

Does a high BNP mean cancer? No — BNP and NT-proBNP are not tumor markers. A high value reflects strain on the heart, not a tumor. (Some cancer treatments can affect the heart and warrant monitoring, but that is a separate matter managed by a cardiologist.)

Low/normal

A low value, below the rule-out cutoff, is generally reassuring: it makes heart failure unlikely in someone being evaluated for shortness of breath.6 This is the whole point of the test — its excellent negative predictive value often lets clinicians avoid unnecessary tests. One important caveat: in people with obesity, levels run lower, so a "normal" BNP or NT-proBNP can be falsely reassuring.9

What raises BNP besides heart failure

Several things move BNP and NT-proBNP independently of heart failure, and they are worth flagging to your physician:

  • Age (up): levels rise naturally with age, which is why seniors have higher cutoffs.6
  • Kidney disease (up): reduced kidney function raises levels, especially NT-proBNP; a BNP result is best read alongside creatinine.8
  • Atrial fibrillation (up): this arrhythmia raises NT-proBNP independently of heart failure.8
  • Pulmonary embolism, pulmonary hypertension, sepsis (up): conditions that stress the right heart lift the numbers; the workup often pairs these markers with a D-dimer when a clot is suspected.1
  • Obesity (down): a high body-mass index lowers levels, which can mask early heart failure.9
  • Sex: at the same age, levels tend to run slightly higher in women.13
  • Medication: sacubitril/valsartan (Entresto) raises BNP without raising NT-proBNP (see above).11

Recent research

From recent PubMed publications and guidelines:

  • A cornerstone for ruling out heart failure. The 2005 PRIDE study showed that an NT-proBNP below 300 pg/mL excludes acute heart failure with a 99% negative predictive value, and validated the age-stratified "positive" cutoffs (about 450 pg/mL under 50, 900 for 50–75, 1800 over 75) still used today.6 This built on the Breathing Not Properly study, which established rapid BNP measurement for diagnosing heart failure in breathless emergency patients.7
  • Guidelines put numbers to the cutoffs. The 2022 AHA/ACC/HFSA heart-failure guideline (Heidenreich et al.) recommends natriuretic peptides for diagnosis, staging, and prognosis, and to guide decisions in patients hospitalized with heart failure.12 The 2021 ESC guideline similarly anchors the outpatient rule-out thresholds (BNP < 35, NT-proBNP < 125 pg/mL).10
  • Context is everything. A 2024 review confirms the markers' strong exclusionary value while stressing that results must be weighted for age, kidney function, and obesity — the number alone can mislead.13 A screening study in people with type 2 diabetes found that a high NT-proBNP became more common with older age and falling kidney function, and was strongly linked to atrial fibrillation.8
  • BNP vs NT-proBNP on Entresto. An analysis of the PARADIGM-HF trial confirmed that sacubitril/valsartan raises BNP — because sacubitril inhibits the enzyme that degrades it — while NT-proBNP is unaffected, so NT-proBNP is the marker to follow on this treatment.11

These findings concern diagnosis and medical management; they do not replace your physician's advice.

Get your BNP or NT-proBNP interpreted by AI DiagMe

A BNP or NT-proBNP is never read alone: its meaning depends on the assay your lab used, your age, your kidney function, any arrhythmia, your weight, and above all your symptoms and echocardiogram. That cross-referencing is what gives the result its real value.

👉 AI DiagMe interprets your lab results — blood, urine, or stool — in plain language, taking your whole profile into account. An informational service that does not provide a diagnosis and complements, never replaces, your physician.

Frequently asked questions

What is a normal BNP level?
In the outpatient setting, a BNP below about 35 pg/mL makes heart failure unlikely; in the emergency room the cutoff is higher (below 100 pg/mL). NT-proBNP has different thresholds — below 125 pg/mL outpatient, below 300 pg/mL in the ER, read by age in acute care. Values vary by assay, so check your own report.56
What is the difference between BNP and NT-proBNP?
They are two different tests from the same proBNP molecule, with different cutoffs. NT-proBNP is inactive, longer-lived, and steadier, and is affected more by kidney function; BNP is the active hormone and clears faster. Crucially, Entresto (sacubitril/valsartan) raises BNP but not NT-proBNP, so NT-proBNP is preferred on that drug. Never compare a BNP number to an NT-proBNP cutoff.34
What does a high BNP mean?
That the heart is under strain. Heart failure is the main concern, but age, kidney disease, atrial fibrillation, pulmonary embolism, and sepsis also raise it. A high value does not confirm heart failure by itself — an echocardiogram and the clinical picture do.112
Can a normal BNP rule out heart failure?
Largely, yes. A low BNP or NT-proBNP has a high negative predictive value: in the PRIDE study, NT-proBNP below 300 pg/mL ruled out acute heart failure with 99% negative predictive value.6 The exception is obesity, which lowers the numbers and can make a normal result falsely reassuring.9
Does kidney disease affect BNP?
Yes. Both peptides are cleared partly by the kidneys, so levels rise when kidney function falls — more so for NT-proBNP. A high value in someone with kidney disease does not necessarily mean heart failure, and physicians read it alongside kidney function tests.8
Does Entresto affect BNP?
Yes. Sacubitril/valsartan (Entresto) blocks neprilysin, the enzyme that degrades BNP, so BNP rises on this drug while NT-proBNP is unaffected. For anyone taking Entresto, NT-proBNP is the reliable marker to monitor.11

Bottom line

BNP and NT-proBNP are hormones the heart releases when its walls are stretched by an overload — their level marks strain on the heart (heart failure), unlike troponin, which marks injury. Remember they are two different tests in pg/mL with their own cutoffs — never cross-compare — and that NT-proBNP is steadier, more kidney-sensitive, and the right marker on Entresto. Their greatest strength is the negative result: a low value makes heart failure unlikely. A high value is non-specific (age, kidney disease, atrial fibrillation, pulmonary embolism, sepsis all raise it; obesity lowers it) and points toward heart failure without proving it — the echocardiogram, your symptoms, and your context decide. No marker is read alone: it is the whole picture your physician interprets, and that AI DiagMe can help clarify, alongside your physician.

Sources

Official U.S. sources and peer-reviewed publications (PubMed) used for this guide:

Footnotes

  1. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol, 2007. PubMed · DOI 2 3 4 5 6 7

  2. Novack ML, Zubair M. Natriuretic Peptide B Type Test. StatPearls, NCBI Bookshelf. Bookshelf ID NBK556136. ncbi.nlm.nih.gov 2 3

  3. Cleveland Clinic — B-type Natriuretic Peptide (BNP) Test. my.clevelandclinic.org 2 3 4

  4. Testing.com — Brain Natriuretic Peptide Test (BNP and NT-proBNP). testing.com 2 3 4

  5. MedlinePlus (U.S. National Library of Medicine, NIH) — Natriuretic Peptide Tests (BNP, NT-proBNP). medlineplus.gov 2 3 4

  6. Januzzi JL, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol, 2005. PubMed · DOI 2 3 4 5 6 7 8 9 10 11

  7. Maisel AS, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002. PubMed · DOI 2 3

  8. Zhou M, et al. Opportunistic screening for asymptomatic left ventricular dysfunction in type 2 diabetes mellitus. Postgrad Med J, 2023. PubMed · DOI 2 3 4 5 6 7 8 9 10

  9. Madamanchi C, et al. Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure. Int J Cardiol, 2014. PubMed · DOI 2 3 4

  10. McDonagh TA, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J, 2021. PubMed · DOI 2 3 4

  11. Myhre PL, et al. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol, 2019. PubMed · DOI 2 3 4

  12. Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation, 2022. PubMed · DOI 2 3 4 5

  13. Vergani M, et al. The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes. J Clin Med, 2024. PubMed · DOI 2 3

Medical disclaimer. This article is provided for informational and educational purposes only; it is not medical advice and does not replace a consultation. Reference ranges vary by laboratory and method: only your physician can interpret your results in your specific context.